In a memo to NACDS chain and associate members today, NACDS president and chief executive officer Steven Anderson, described detailed results of the 2018 Congressional elections from a pharmacy-specific perspective. The memo described changes in the leadership of key healthcare committees, the election results for Congressional champions of specific pharmacy issues, and other insights. The
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is applauding the enactment of an electronic prescribing bill (HB 353) in Pennsylvania that will help to prevent opioid abuse. Pennsylvania Gov. Tom Wolf (D) signed the legislation yesterday. The new law requires that all controlled substance prescriptions be electronically prescribed, with certain exceptions. The law takes
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) was invited to a White House event today titled “A Year of Historic Action to Combat the Opioid Crisis,” at which the President signed the SUPPORT for Patients and Communities Act (H.R. 6) – legislation that reflects aspects of all four of NACDS’ policy recommendations regarding opioid-abuse prevention.
ARLINGTON, Va. — NACDS has been invited back to the White House for an event on Wednesday, October 24, that is titled “A Year of Historic Action to Combat the Opioid Crisis.” We also anticipate soon President Trump’s signing of the SUPPORT for Patients and Communities Act – which reflects aspects of all four of the policy
ARLINGTON, Va. – At the invitation of the White House, the National Association of Chain Drug Stores (NACDS) today participated with President Trump in the signing ceremony for the Patient Right to Know Prices Act (S. 2554) and the Know the Lowest Price Act (S. 2553). Representing NACDS at the ceremony were NACDS vice chairman
WASHINGTON — Retail pharmacy advocates applauded the House of Representatives for unanimously passing two bipartisan bills that aim to lower drug costs. The bills — the Patient Right to Know Drug Prices Act and the Know the Lowest Price Act — had originated in the Senate, where each had gained earlier approval. The bills were
ARLINGTON, Va. – This week the U.S. Senate passed the opioid-abuse-prevention legislation that reflects aspects of all four of the policy topics recommended by the National Association of Chain Drug Stores (NACDS), and that the U.S. House of Representatives passed on September 28. The bill now goes to President Trump for consideration, and the White House
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS), the American Public Health Association (APHA) and the CDC Foundation will host a pre-conference workshop designed to convene public health, pharmacy and health care stakeholders to identify gaps in patient care access, leverage partnerships, and determine practices for improved population health outcomes. The forum
ARLINGTON, Va. – The opioid-abuse-prevention legislation crafted by U.S. Senate and U.S. House of Representatives negotiators reflects aspects of all four of the policy topics recommended by the National Association of Chain Drug Stores (NACDS). The House passed the bill today, and the Senate anticipates voting next week. The SUPPORT for Patients and Communities Act (H.R. 6) includes the
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) is recognizing the leadership of the Massachusetts state legislature, under the leadership of House Speaker Robert DeLeo (D) and Senate President Karen Spilka (D), along with Governor Charlie Baker (R), for the enactment of House Bill 4742. The new law requires that on or after January 1,
During the commemoration of National Immunization Awareness Month in August, NACDS will be promoting a host of story lines of importance to public health and to pharmacy’s role as the face of neighborhood healthcare. The past decade has seen tremendous advancement for pharmacy’s role in protecting Americans with vaccinations. To provide the background, it was
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) today welcomed the Senate Health, Education, Labor and Pensions Committee’s passage of the Patient Right to Know Drug Prices Act (S. 2554). In a letter endorsing the legislation, NACDS wrote, “NACDS believes gag clauses should not be allowed in contracts between health plans and
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) has submitted comments to Health and Human Services Secretary Alex Azar in response to the agency’s request-for-information on drug-pricing public policy issues. “We believe there are numerous opportunities to achieve the goals of lowering the financial burdens on patients and making prescription drugs more
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) RxIMPACT grassroots advocacy program has mobilized to support a U.S. Senate initiative urging action by U.S. Secretary of Health and Human Services Secretary Alex Azar on direct and indirect remuneration (DIR) fee reform in Medicare Part D. NACDS RxIMPACT pharmacy advocates are urging Senators to